Developed in just six weeks, the rapid test can detect a SARS-CoV-2 coronavirus infection in patients in under two and a half hours. The test for COVID-19 can help medical facilities make fast diagnoses and play a part in containing the coronavirus pandemic.



Click here for reference

The US drug regulator has granted its first emergency-use approval for a new coronavirus test that takes advantage of the gene-editing technology CRISPR on 6 May.

The US Food and Drug Administration’s (FDA) emergency-use authority allows it to make tests and drugs available faster than usual in a public-health emergency. The new diagnostic kit is based on an approach co-developed by CRISPR pioneer Feng Zhang at the Broad Institute of MIT and Harvard in Cambridge, Massachusetts. It ...

A group of researchers, including some at IMIM, design a new support tool for the diagnosis of COVID-19 which uses Artificial Intelligence. It has been trained with more than 6,000 chest X-rays of patients from the Hospital del Mar.




The researcher at the Hospital del Mar Medical Research Institute (IMIM) and physician at the Hospital del Mar Emergency Service, Max Hardy-Werbin, as well as the bioinformatician at the Pathological Anatomy Service of the same hospital, Joan Gi...

Liming Bio has launched The StrongStep® COVID-19 IgG/IgM Combo Test. It is a rapid immunochromatographic assay for the simultaneous detection of IgG and IgM antibodies to SARS-CoV-2 virus in human whole blood, serum or plasma. The assay is used as an aid in the diagnosis of COVID-19.

Click here for reference

A combination of three antiviral drugs plus an immune system booster seemed to help patients recover more quickly from coronavirus infections, doctors in Hong Kong reported Friday.



They said the approach needs more testing but it could offer another treatment possibility for Covid-19 patients. Currently the only authorized treatment is the experimental antiviral drug remdesivir, which also shortens the duration of illness but is limited in supply.
Dr. Kwok-Yung Yuen at H...

HP is providing several free-access 3D printing designs for essential materials in the Covid-19 fight, and other additional resources. These materials include face shields, masks, CPAP components, personal accessories, and ventilator components. The webpage is updated regularly. 

Click here to access website

Effective antiviral therapy is important for tackling the coronavirus disease 2019 (COVID-19) pandemic. We assessed the efficacy and safety of combined interferon beta-1b, lopinavir–ritonavir, and ribavirin for treating patients with COVID-19. This was a multicentre, prospective, open-label, randomised, phase 2 trial in adults with COVID-19 who were admitted to six hospitals in Hong Kong. Patients were randomly assigned (2:1) to a 14-day combination of lopinavir 400 mg and ritonavir 100 m...

Imaging COVID-19 AI initiative is a multicenter European project to enhance computed tomography (CT) in the diagnosis of COVID-19 by using artificial intelligence. The project group will create a deep learning model for automated detection and classification of COVID-19 on CT scans, and for assessing disease severity in patients by quantification of lung involvement.




Many different hospitals and institutions across Europe will collaborate to rapidly develop an artificia...

Imaging COVID-19 AI initiative is a multicenter European project to enhance computed tomography (CT) in the diagnosis of COVID-19 by using artificial intelligence. The project group will create a deep learning model for automated detection and classification of COVID-19 on CT scans, and for assessing disease severity in patients by quantification of lung involvement.




Many different hospitals and institutions across Europe will collaborate to rapidly develop an artificia...

AMBOSS is providing a number of programs for medical students, clinicians, and institutions and educators, in order to help them continue their learning as well as help them confidentially process and apply their medical knowledge at the point-of-care. 

For clinicians: Find all the clinical knowledge you need to know about COVID-19 in English, Spanish, French, Italian, Portuguese, and German in our medical knowledge library.

For students: Face new challenges in the clini...

Severe acute respiratory syndrome CoV-2 (SARS-CoV-2) caused the corona virus disease 2019 (COVID-19) cases in China and has become a public health emergency of international concern1. Because angiotensin-converting enzyme 2 (ACE2) is the cell entry receptor of SARS-CoV5, we used transgenic mice bearing human ACE2 and infected with SARS-CoV-2 to study the pathogenicity of the virus. Weight loss and virus replication in lung were observed in hACE2 mice infected with SARS-CoV-2. The typical ...

Researchers say people can catch mild, cold-causing coronaviruses twice in the same year.



Starting in the fall of 2016 and continuing into 2018, researchers at Columbia University in Manhattan began collecting nasal swabs from 191 children, teachers, and emergency workers, asking them to record when they sneezed or had sore throats. The point was to create a map of common respiratory viruses and their symptoms, and how long people who recovered stayed immune to each one.